Amblyopia Therapy: An Update

REFERENCES

• Awan M, Proudlock FA, Gottlob I. A randomised controlled trial of unilateral strabismic and mixed amblyopia using occlusion dose monitor to record compliance. Invest Ophthalmol Vis Sci. 2005;46:1435–1439.
   PubMed Web of Science ®Google Scholar
• Cole SR, Beck RW, Moke PS, et al. The Amblyopia Treatment Index. J AAPOS. 2001;5:250–254.
   PubMed Web of Science ®Google Scholar
• Cotter SA, Holmes JM, Foster N, Melia M, Pediatric Eye Disease Investigator Group. Optical treatment of strabismic and combined strabismic-anisometropic amblyopia IOVS E-ABSTRACT; 2011.
   Google Scholar
• Dixon-Woods M, Awan M, Gottlob I. Why is compliance with occlusion therapy for amblyopia so hard? A qualitative study. Arch Dis Child. 2006;91:491–494.
   PubMed Web of Science ®Google Scholar
• Fielder AR, Irwin M, Auld R, Cocker KD, Jones HS, Moseley MJ. Compliance monitoring in amblyopia therapy: objective monitoring of occlusion. Br J Ophthalmol. 1995;79:585–589.
   PubMed Web of Science ®Google Scholar
• Foley-Nolan A, McCann A, O’Keefe M. Atropine penalisation versus occlusion as the primary treatment for amblyopia. Br J Ophthalmol. 1997;81:54–57.
   PubMed Web of Science ®Google Scholar
• Holmes JM, Repka MX, Kraker RT, Clarke MP. Treating of amblyopia. Strabismus. 2006;14:37–42.
   PubMedGoogle Scholar
• Loudon SE, Polling JR, Simonsz HJ. Electronically measured compliance with occlusion therapy for amblyopia is related to visual acuity increase. Graefes Arch Clin Exp Ophthalmol. 2003;24:176–180.
   Google Scholar
• Loudon SE, Passchier J, Chaker L, et al. Psychological causes of non-compliance with electronically monitored occlusion therapy for amblyopia. Br J Ophthalmol. 2009;93:1499–1503.
   PubMed Web of Science ®Google Scholar
• Loudon SE, Fronius M, Looman C, Awan M, Simonsz M, van der Maas, et al. Predictors and a remedy for noncompliance with amblyopia therapy in children measured with the occlusion dose monitor. Invest Ophthalmol Vis Sci. 2006;47:4393–4400.
   PubMed Web of Science ®Google Scholar
• Massie H. Fixing eye for occlusion: survey of 1,000 cases of patients receiving occlusion of the fixing eye. Trans Ophthalmol Soc Aust. 1965;24:39–46.
   Google Scholar
• Moseley MJ, Neufield M, McCarry B et al.. Remediation of refractive amblyopia by optical correction alone. Ophthal Physiol Opt. 2002;22:296–299
   PubMed Web of Science ®Google Scholar
• Newsham D. A randomised controlled trial of written information: the effect on parental non-compliance with occlusion therapy. Br J Ophthalmol. 1997;86:787–791.
   Google Scholar
• Newsham D. The effect of recent amblyopia research on current practice in the UK. Br J Ophthalmol. 2010;94:1352–1357.
   PubMed Web of Science ®Google Scholar
• Pediatric Eye Disease Investigator Group. A randomized trial to evaluate 2 hours of daily patching for strabismic and anisometropic amblyopia in children. Ophthalmology. 2006a;113:904–912.
   PubMedGoogle Scholar
• Pediatric Eye Disease Investigator Group. Treatment of anisometropic amblyopia in children with refractive correction. Ophthalmology. 2006b;113:895–903.
   PubMed Web of Science ®Google Scholar
• Pediatric Eye Disease Investigator Group. Treatment of strabismic with refractive correction. Ophthalmology. 2007;143:1060–1063.
   Google Scholar
• Pediatric Eye Disease Investigator Group. A randomized trial of atropine vs. patching for treatment of moderate amblyopia in children. Arch Ophthalmol. 2002;120:268–278.
   PubMed Web of Science ®Google Scholar
• Pediatric Eye Disease Investigator Group. Impact of patching and atropine treatment on the child and family in the amblyopia treatment study. Arch Ophthalmol. 2003;121(11):1625–1632.
   PubMedGoogle Scholar
• Pediatric Eye Disease Investigator Group. A randomized trial of atropine regimens for treatment of moderate amblyopia in children. Ophthalmology. 2004;111:2076–2085.
   PubMed Web of Science ®Google Scholar
• Pediatric Eye Disease Investigator Group. Pharmacologic plus optical penalization treatment for amblyopia: results of a randomized trial. Arch Ophthalmol. 2009;127:22–30.
   PubMedGoogle Scholar
• Pediatric Eye Disease Investigator Group. A randomized trial of patching regimens for treatment of moderate amblyopia in children. Arch Ophthalmol 2003a;121:603–611.
   PubMed Web of Science ®Google Scholar
• Pediatric Eye Disease Investigator Group. A randomized trial of prescribed patching regimens for treatment of severe amblyopia in children. Ophthalmology. 2003b;110:2075–87.
   PubMed Web of Science ®Google Scholar
• Pediatric Eye Disease Investigator Group. Randomized trial of treatment of amblyopia in children aged 7 to 17 years. Arch Ophthalmol. 2005;123(4):437–47.
   PubMedGoogle Scholar
• Pradeep A, Proudlock FA, Awan M, Bush G, Gottlob I. Can Amblyopia Treatment Be Optimised? Invest Ophthalmol Vis Sci. 2010;51: E-Abstract 4756.
   Google Scholar
• Repka MX, Kraker RT, Beck RW, et al. Treatment of severe amblyopia with atropine: results from two randomized clinical trials. J AAPOS. 2009;13:258–263.
   PubMed Web of Science ®Google Scholar
• Scheiman MM, Hertle RW, Kraker RT, Beck RW, Birch EE, Felius J, Holmes JM, et al. Pediatric Eye Disease Investigator Group. Patching vs atropine to treat amblyopia in children aged 7 to 12 years: a randomized trial. Arch Ophthalmol. 2008;126:1634–1642.
   PubMedGoogle Scholar
• Stewart CE, Moseley MJ, Fielder AR, Stephens DA, and the MOTAS cooperative. Refractive adaptation in ambyopia: quantification of effect and implications for practice. Br J Ophthalmol. 2004a;88:1552–1556.
   PubMed Web of Science ®Google Scholar
• Stewart CE, Moseley MJ, Stephens DA, Fielder AR & the MOTAS cooperative. The Treatment Dose-Response in Amblyopia Therapy: results from the Monitored Occlusion Treatment of Amblyopia Study (MOTAS) Invest Ophthalmol Vis Sci. 2004b;45:3048–3054.
   Google Scholar
• Stewart CE, Stephens DA, Fielder AR, Moseley MJ, ROTAS Cooperative. objectively monitored patching regimens for treatment of amblyopia: randomised trial. BMJ. 2007;335:707–711.
   PubMed Web of Science ®Google Scholar
• Stewart CE, Fielder AR, Stephens DA, Moseley MJ. Design of the Monitored Occlusion Treatment of Amblyopia Study (MOTAS). Br J Ophthalmol. 2002;86:915–919.
   PubMed Web of Science ®Google Scholar